Manufacturers Face Potential Roadblock to Early Challenges to Biologic Drug Patents
By EsqSocial Corporation 22/11/13
Biologic drugs have become increasingly popular in recent years, and now serve as standard treatment options for diseases such as diabetes, anemia, cancer, hepatitis, and multiple sclerosis. Biologics are a class of drugs or vaccines that are...
By: K&L Gates LLP